Hedge Fund - Kynam Capital
Biocryst Pharmaceuticals Inc (BCRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $73,058,903 | 4.67% | 9,366,526 | $7.23 |
| 2 | 2025 - Q3 (2025-09-30) | $71,272,149 | 5.31% | 9,390,270 | $8.33 |
| 3 | 2025 - Q2 (2025-06-30) | $75,835,128 | 8.16% | 8,463,742 | $9.31 |
| 4 | 2025 - Q1 (2025-03-31) | $66,963,923 | 5.63% | 8,928,523 | $8.07 |
| 5 | 2024 - Q4 (2024-12-31) | $68,321,967 | 4.03% | 9,085,368 | $7.59 |
| 6 | 2024 - Q3 (2024-09-30) | $69,048,797 | 5.29% | 9,085,368 | $7.60 |
| 7 | 2024 - Q2 (2024-06-30) | $54,549,068 | 4.2% | 8,826,710 | $5.52 |
| 8 | 2024 - Q1 (2024-03-31) | $33,159,654 | 3.47% | 6,527,491 | $5.62 |
| 9 | 2023 - Q4 (2023-12-31) | $27,554,000 | 3.05% | 4,600,000 | $5.79 |
| 10 | 2023 - Q3 (2023-09-30) | $22,183,006 | 3.62% | 3,133,193 | $7.18 |
| 11 | 2023 - Q2 (2023-06-30) | $20,051,307 | 2.75% | 2,848,197 | $8.02 |
| 12 | 2023 - Q1 (2023-03-31) | $8,340,000 | 1.07% | 1,000,000 | $9.63 |
| 13 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $12.47 |
| 14 | 2022 - Q3 (2022-09-30) | $5,482,000 | 1.15% | 435,117 | $12.87 |
| 15 | 2022 - Q2 (2022-06-30) | $9,909,000 | 2.53% | 936,563 | $10.32 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center